Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Net Income: 2009-2024

Historic Net Income for Fortress Biotech (FBIO) over the last 16 years, with Dec 2024 value amounting to -$120.9 million.

  • Fortress Biotech's Net Income rose 133.03% to $8.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$75.2 million, marking a year-over-year increase of 36.67%. This contributed to the annual value of -$120.9 million for FY2024, which is 21.60% up from last year.
  • According to the latest figures from FY2024, Fortress Biotech's Net Income is -$120.9 million, which was up 21.60% from -$154.2 million recorded in FY2023.
  • Fortress Biotech's Net Income's 5-year high stood at -$103.0 million during FY2020, with a 5-year trough of -$213.9 million in FY2022.
  • For the 3-year period, Fortress Biotech's Net Income averaged around -$163.0 million, with its median value being -$154.2 million (2023).
  • As far as peak fluctuations go, Fortress Biotech's Net Income crashed by 60.07% in 2021, and later grew by 27.94% in 2023.
  • Yearly analysis of 5 years shows Fortress Biotech's Net Income stood at -$103.0 million in 2020, then crashed by 60.07% to -$164.9 million in 2021, then fell by 29.76% to -$213.9 million in 2022, then increased by 27.94% to -$154.2 million in 2023, then grew by 21.60% to -$120.9 million in 2024.